U.S. Oil and Gas Stock News

News (NWSA) shares have seen some movement lately, catching the attention of investors who are curious about what might be driving the stock’s recent changes. In the past month, the stock has edged up just under 1%. See our latest analysis for News. After a long stretch of sideways trading, News shares have lost some momentum in recent months, with a 1-year total shareholder return of -7.98% and a 90-day share price return of -11.45%. Even with a healthy run over the last five years, recent...

Fortive (FTV) shares have rebounded about 6% over the past month, even as the stock remains down year to date. Investors are watching closely as recent performance hints at shifting momentum following a stretch of slower growth. See our latest analysis for Fortive. Fortive’s recent recovery has started to catch investors’ attention, with its 6% one-month share price return providing a welcomed shift after a tough stretch. Although the stock is still down significantly year to date, the steady...

Bausch Health Companies (NYSE:BHC) has announced the commercial expansion of its OraPharma business into Canada and Puerto Rico. By entering these markets, the company aims to broaden access to periodontal disease treatments and foster new partnerships. See our latest analysis for Bausch Health Companies. Despite Bausch Health Companies’ big move to expand its OraPharma dental products into Canada and Puerto Rico, investors have seen mixed signals. The stock has posted a 3.8% one-month share...

Nektar Therapeutics (NKTR) announced a $110 million follow-on equity offering, along with new shelf registrations for multiple securities. Moves like this can reshape the company's capital position and influence how investors gauge its future outlook. See our latest analysis for Nektar Therapeutics. This fresh fundraising push comes shortly after Nektar Therapeutics’ recent FDA fast track designations, new product data, and a third-quarter earnings report showing narrower year-over-year...

Earlier this month, Booking Holdings Inc. completed a €750 million fixed-rate senior unsecured note offering, introducing 3% callable Eurobonds due in November 2030 as part of its capital-raising efforts. The announcement comes alongside positive quarterly results and increased annual savings forecasts, highlighting management’s confidence in both operational momentum and cost transformation initiatives. To better understand what these events signal, we'll explore how improved savings...

PureCycle Technologies, Inc. recently grabbed headlines after winning the 2025 U.S. Plastics Pact Sustainable Packaging Innovation Award. The company also posted quarterly results that showed narrower losses and announced new regulatory milestones in Europe. See our latest analysis for PureCycle Technologies. After a surge of attention from its sustainability award win and the appointment of a new director, PureCycle’s 1-day share price return of 3.49% hints at rising optimism. However, with...

Insulet (PODD) is catching attention after releasing its third quarter results, showing clear jumps in sales and net income from last year. The company also boosted its revenue outlook for its Omnipod line, which signals confidence in future growth. See our latest analysis for Insulet. Momentum has been building for Insulet this year, with its upbeat earnings and a boost in revenue guidance helping to drive investor optimism. The share price is up 29.5% year-to-date, and the company’s...

Earlier this month, Centene Corporation announced expanded Ambetter health insurance plan offerings for 2026 in Arizona, Mississippi, and Georgia, emphasizing affordable plans, customizable coverage, and enhanced member benefits such as Ambetter Perks, My Health Pays rewards, and 24/7 telehealth services. This expansion highlights Centene's ongoing focus on consumer-friendly digital enrollment, value-added programs, and tailored employer solutions, which may play a role in membership growth...

Aptiv (APTV) delivered strong third-quarter earnings that surpassed expectations, sparking investor interest ahead of its upcoming analyst day. The company is also set to discuss a possible spin-off of its software division, which hints at a new strategic focus. See our latest analysis for Aptiv. Aptiv’s upbeat earnings and its fresh robotics partnership with Robust.AI have put the spotlight back on the company’s transformation story, helping spark considerable momentum in the stock. While...

Clarivate recently reported its fiscal Q3 2025 results, showing a modest revenue increase driven by higher transactional sales in the government and academic sectors, and raised its full-year revenue outlook amid favorable currency effects. An interesting insight is that while transactional book sales and currency movements provided a boost, recurring subscription revenue growth came in below expectations, signaling ongoing challenges to sustainable long-term growth. We'll explore how...

ManpowerGroup (MAN) shares have continued their steady slide in recent weeks, with the stock down 15% over the past month. Investors are watching for signs of recovery as the staffing leader faces ongoing challenges. See our latest analysis for ManpowerGroup. ManpowerGroup's challenges have only accelerated this year, with the stock’s 30-day share price return at -15% and its year-to-date decline nearing 50%. A one-year total shareholder return of -52% highlights how far sentiment and...

Crinetics Pharmaceuticals (CRNX) just released its third quarter financials, showing a wider net loss compared to last year. This update is important for investors keeping an eye on the company’s trajectory. See our latest analysis for Crinetics Pharmaceuticals. Despite the steeper losses just reported, Crinetics Pharmaceuticals has climbed sharply in recent months, with a 43% share price return over the last quarter. However, momentum has yet to fully recover from longer-term declines...

Tetra Tech reported record financial results for the fourth quarter and fiscal year 2025, including record net revenue, operating income, and earnings per share, alongside a 12% year-on-year increase in its quarterly dividend payable on December 12, 2025. The company highlighted strong growth in high-end water infrastructure and digital automation services, while also announcing major contract wins with U.S. defense agencies and international clients, contributing to an expanding project...

Nelnet recently reported third-quarter and nine-month earnings, with net income reaching US$106.68 million for the quarter and US$370.7 million year-to-date, and also declared a US$0.33 per share dividend to be paid in December 2025. The company’s results reflect a dramatic rise in profitability compared to the previous year, driven by substantial gains in both quarterly and year-to-date earnings per share. We'll examine how Nelnet's significant earnings jump and shareholder dividend...

In recent announcements, MarketAxess Holdings reported third quarter and nine-month financial results, affirmed its quarterly dividend of US$0.76 per share, completed a US$95.33 million share buyback, and revealed the imminent launch of standardized Opening and Closing Auctions for U.S. credit trading on its platform. Consulting with major institutional participants to develop its new auction protocol highlights MarketAxess’s ongoing focus on enhancing liquidity and price discovery in the...

Hubbell recently completed its acquisition of DMC Power, enhancing its utility connector portfolio with advanced solutions for high-growth substation markets. An important detail is that the company expects the DMC Power acquisition to add approximately $0.20 per share in adjusted earnings by 2026, strengthening Hubbell's position in grid and electrification investments. We'll explore how the completed DMC Power acquisition may influence Hubbell's investment narrative and outlook for utility...

Strategic Education (STRA) recently posted a third quarter earnings report showing higher revenue and greater profitability, mainly supported by steady growth from its Sophia Learning and Workforce Edge platforms. Management highlighted ongoing operational efficiencies and robust employer-affiliated enrollments as positive trends. See our latest analysis for Strategic Education. Alongside the solid earnings beat, Strategic Education has been active with its buyback program, repurchasing...

NextDecade (NEXT) is drawing renewed attention after Hanwha Aerospace boosted its position by acquiring nearly 592,000 shares. At the same time, the company advanced its Rio Grande LNG project with final investment decisions and $13.4 billion in project funding. See our latest analysis for NextDecade. NextDecade’s recent operational milestones and insider buying have helped steady investor sentiment, even as near-term share price performance remains volatile. Despite a sharp pullback with a...

Impinj (PI) shares have faced pressure over the past month, with the stock declining nearly 29%. Investors seem to be weighing the company’s fundamentals and considering whether current levels could present a potential long-term opportunity. See our latest analysis for Impinj. After a long stretch of gains, Impinj’s 1-year total shareholder return is now down 19.3% as momentum cooled sharply in recent weeks. While the latest 1-month share price return of -29.3% captures the recent slide, the...

Ulta Beauty (ULTA) shares caught investor attention as the company announced it will end its long-running shop-in-shop partnership with Target in August 2026 and opened its first standalone store in the Middle East. These business moves could shape Ulta's growth outlook going forward. See our latest analysis for Ulta Beauty. Ulta Beauty's share price has gained solid momentum this year, with a 23.3% share price return year-to-date and a strong 44.96% total shareholder return over the past...

Apogee Therapeutics (APGE) is in the spotlight after sharing positive interim data from its Phase 1 trial of APG333. The experimental antibody showed a longer half-life and favorable safety profile in healthy volunteers. See our latest analysis for Apogee Therapeutics. Momentum around Apogee Therapeutics has been building fast, with the 1-day share price return jumping 4% after upbeat Phase 1 trial results and a successful $345 million capital raise. That excitement has fueled a striking...

Agios Pharmaceuticals announced that new clinical and preclinical data on mitapivat, its oral pyruvate kinase activator, were featured in multiple presentations at the 67th American Society of Hematology (ASH) Annual Meeting held in Orlando from December 6-9, 2025. The presentations highlighted mitapivat's potential to significantly reduce transfusion needs in thalassemia and provided early evidence of protection against heart complications, an important concern for patients with hemolytic...

Molson Coors Beverage (TAP) stock dipped slightly this week, catching some attention from investors tracking longer-term trends. Shares have drifted nearly 19% lower since January, raising questions about the outlook and underlying factors shaping its trajectory. See our latest analysis for Molson Coors Beverage. Molson Coors Beverage’s share price has steadily lost ground over the last year, closing recently at $46.44, and momentum seems to be fading after a string of weaker total...

Organon & Co. recently reported third quarter 2025 earnings, showing sales of US$1.60 billion and net income of US$160 million, while also lowering its full-year revenue guidance to a range of US$6.20 billion to US$6.25 billion. The company's latest results reflected a significant drop in net income compared to the prior year, signaling that margin pressures and revised expectations are influencing its financial outlook. We'll explore how Organon's reduced full-year revenue outlook and...